PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced that Michael Klichinsky, PharmD, PhD, Co-founder and Chief Scientific Officer, will present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference on Tuesday, February 25, at 10:30 am ET.
The company, which specializes in advancing macrophage-based immunotherapies, continues to establish its position in the cell therapy sector through active engagement in key industry events. The presentation will provide insights into Carisma’s ongoing initiatives and scientific advancements.
An audio webcast of the presentation will be accessible in the Investor Events section of the company’s Investor Relations webpage. For those unable to attend live, the recording will be archived for a limited time.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.